Hemagen Diagnostics Operating Margin vs. Revenue
| HMGNDelisted Stock | USD 0.0001 0.00 0.00% |
For Hemagen Diagnostics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Hemagen Diagnostics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Hemagen Diagnostics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Hemagen Diagnostics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Hemagen Diagnostics over time as well as its relative position and ranking within its peers.
Hemagen |
Hemagen Diagnostics Revenue vs. Operating Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Hemagen Diagnostics's current stock value. Our valuation model uses many indicators to compare Hemagen Diagnostics value to that of its competitors to determine the firm's financial worth. Hemagen Diagnostics is one of the top stocks in operating margin category among its peers. It is rated # 3 in revenue category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Hemagen Diagnostics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Hemagen Diagnostics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Hemagen Revenue vs. Operating Margin
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Hemagen Diagnostics |
| = | (0.11) % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Hemagen Diagnostics |
| = | 4.04 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Hemagen Revenue vs Competition
Hemagen Diagnostics is rated # 3 in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 493.18 Million. Hemagen Diagnostics maintains roughly 4.04 Million in revenue contributing less than 1% to equities under Health Care industry.
Hemagen Diagnostics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Hemagen Diagnostics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Hemagen Diagnostics will eventually generate negative long term returns. The profitability progress is the general direction of Hemagen Diagnostics' change in net profit over the period of time. It can combine multiple indicators of Hemagen Diagnostics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company was founded in 1985 and is based in Columbia, Maryland. Hemagen Diagnostics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 15 people.
Hemagen Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Hemagen Diagnostics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Hemagen Diagnostics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Hemagen Diagnostics' important profitability drivers and their relationship over time.
Use Hemagen Diagnostics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Hemagen Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hemagen Diagnostics will appreciate offsetting losses from the drop in the long position's value.Hemagen Diagnostics Pair Trading
Hemagen Diagnostics Pair Trading Analysis
The ability to find closely correlated positions to Hemagen Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hemagen Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hemagen Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hemagen Diagnostics to buy it.
The correlation of Hemagen Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hemagen Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hemagen Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Hemagen Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Hemagen Diagnostics position
In addition to having Hemagen Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Warren Buffett Holdings Thematic Idea Now
Warren Buffett Holdings
A long-term portfolio of publicly-traded stocks on US exchanges that are owned by Warren Buffett's holding company Berkshire Hathaway. The Warren Buffett Holdings theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Warren Buffett Holdings Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Hemagen Pink Sheet
If you are still planning to invest in Hemagen Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hemagen Diagnostics' history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |